INTRODUCTION
Mycobacterium leprae is the causative agent of leprosy and is an obligate intracellular parasite. It has only been observed to divide inside host cells [1, 2] and cannot, at present, be cultured axenicatty.
One of the reasons for its dependence upon the host cell may be a loss of some metabolic capabilities, as has been shown in other parasitic microbes [3, 4] . So far, it appears that M. leprae is incapable of synthesising the purine ring de novo [5, 6] and thus requires an exogenous supply of purine. In this work, the ability of M. leprae to Correspondence to: Paul R. Wheeler, Department of Biochemistry, University of Hull, Hull HU6 7RX, U.K. synthesize the pyrimidine ring has been investigated to determine whether or not it is dependent upon its environment for a supply of pyrimidines for nucleic acid synthesis.
MATERIALS AND METHODS

Mycobacteria used
Suspensions and extracts of M. leprae were prepared as described previously [5, 14] . Additionally, a few pilot and a few comparative experiments were done using suspensions of intact M.
microti and M. smegmatis, obtained as described previously [5] .
Incubations of intact mycobacteria with radioisotopically labelled substrates
These were done exactly as described in a previous paper [5] , except that [U-14C]aspartate (sodium salt, supplied at 270 Ci/mol from Amersham) was used in some incubations at 5 ttCi/ml and 100/~M (incubation volume was 300 /xl), and unlabelled t-asparagine could be omitted from incubation buffer without having any discernable effect.
lism [5] . Each hydrolysate was redissolved in 100 /~1 0.1 M HC1 and applied to a Dowex 50 (200-400 mesh) column (60 mm × 5 mm diam.) in 0.1 M HC1 and eluted with 2.6 ml 0.1 M HC1. Authentic labelled materials eluted under these conditions as follows: [U-14C]aspartate, 0.8% of radioactivity applied; [U-a4C]uracil, 95% of radioactivity applied. Other amino acids eluted similarly to aspartate and cytidine, UMP and UTP eluted similarly to uracil. Thus when most of the radioactivity in a hydrolysate eluted through the Dowex column, most corresponds to pyrimidine--this could be confirmed by TLC as described in the previous paper [5] . However, if very little (< 5%) of the hydrolysate eluted through the column, most corresponds to amino acids, perhaps carried through into the nucleic acid fraction or perhaps from protein contaminating the nucleic acid fraction.
Enzyme assays
All were performed at 34°C with 0.5 to 2.5 mg protein (from mycobacterial extracts)/ml. When samples were applied to TLC as part of assays, areas corresponding to product and substrate were cut out after development, and the proportion of radioactivity in the product was worked out.
(a) Aspartate transcarbamylase (EC 2.1.3.2) as in [7] but the assay volume was 100 /~1, and the enzyme reaction was stopped with 100 #1 antipyrine mixture. Alternatively, the reaction volume was 25 #1 and included 0.25 gCi [U-14C]aspartate, and 5 #1 samples were taken at intervals up to 50 min, mixed with carrier carbamyl aspartate and aspartic acid (20 nmol each) applied to chromogram TLC plates (Eastman-Kodak cellulose TLC plates), and developed with butan-l-ol/glacial acetic acid/distilled H20 (20/2/5 by vol.).
(b) Dihydroorotate synthase (EC 3.5.2.3) was assayed in the direction dihydroorotate carbamyl aspartate by the antipyrine method [8] but with an assay volume of 100 #1, or in the biosynthetic direction (carbamyl aspartate --, dihydroorotate) as follows: Aspartate transcarbamylase (0.1 unit, from Streptococcus faecalis, obtained from Sigma) was added to 40 ~tM L-aspartate (10 #Ci rn1-1) and 1 mM carbamyl phosphate in 30 mM tris-HC1 (pH 8.5), final volume: 500 /tl, and incubated for 20 min at 37 o C. The reaction was stopped by adding 1.5 ml methanol, and aspartate transcarbamylase activity virtually eliminated by incubating for a further 15 rain at 37 °C and then drying the material (in 100 /~1 aliquots) under vacuum. The reaction mixture made in this way contained 80% of the radioactivity in carbamyl aspartate. Each aliquot was stored at -20°C until required then reconstituted by adding distilled water, or dilute acetic acid to pH 6.5, and crude extract to a final volume of 25 ~1. As a result of pilot experiments with extracts from M. smegmatis and M. microti all incubations with M. leprae extracts were done at pH 6.5. Incubations with mycobacterial extracts were for up to 100 min, with 5 ~tl samples being taken at intervals, mixed with carrier carbamyl aspartate and dihydroorotate (50 nmol each) and applied to Whatman No. 1 chromatography paper. Descending chromatography was performed for 48 h with propan-2-ol/880 NH3/distilled H20 (73/10/17 by vol.) to separate orotate and dihydroorotate from carbamyl aspartate, aspartate and oxaloacetate.
For (a) and (b), material was detected after chromatographic development by spraying with 0.04% bromocresol in ethanol/distilled water (96 : 4 by vol.) including 0.1 M NaOH just sufficient to turn blue.
(c) Attempts were made to detect dihydroorotate dehydrogenase (EC 1.3.3.1) by methods described in [9, 10] , as well as with 10 mM orotate, 0.2 mM NADH in 70 mM tris HC1, pH 7.5 or 9.0. 
RESULTS AND DISCUSSION
All the enzymes unique to the de novo pyrimidine biosynthetic pathway were readily detected in extracts of M. leprae ( No radioactivity appeared in the (pyrimidine) nucleotide pool, which was sampled using DE-81 filters as in [5] . Two results suggest that the reason why pyrimidine biosynthesis cannot be detected in intact M. leprae is a result of strong metabolic controls acting on and inhibiting pyrimidine biosynthesis in mycobacteria isolated from the host and not metabolic incompetence on the part of M. leprae. Firstly M. mieroti, a competent and laboratory cultivatable bacterium, harvested from mice, incorporated [14C]aspartate into pyrimidines at 810 ___ 110 (SE of mean) dpm/101° bacteria/24 h, a readily detectable but very low rate compared with that [9250 + 380 (SE of mean) dpm/101° bacteria/24 h] observed in M. microti grown in Dubos (pyrimidine-free) medium. Secondly, when UTP or ATP, common inhibitors of ATCase which is the key enzyme for feedback control of pyrimidine biosynthesis, were added to extracts (see above), inhibition of M. leprae ATCase could be shown. A recent report shows that mycobacterial ATCase from M. smegmatis is even more strongly inhibited by CTP [12] . An attempt to relieve such feedback inhibition in intact M. leprae by starving the bacteria failed, probably because during the attempt to starve the bacteria, the number of viable organisms would have fallen dramatically [13] . Another precursor of pyrimidine biosynthesis supplied to intact mycobacteria, 14CO2, was incorporated into pyrimidines at only -10% the rate of [U-14C]aspartate, when supplied in pilot experiments at 100 ~tM, 2.6 #Ci m1-1 to suspensions of M. smegmatis or M. microti grown in Dubos medium and not at a detectable rate when supplied to a single suspension of M. leprae.
It appears then that strong feedback inhibition of the enzymes of pyrimidine biosynthesis is the major reason for the failure to detect pyrimidine biosynthesis in intact M. leprae. However, the activity of all the individual enzymes in the pathway could be detected because when the bacteria (each contaimng -10 -13 ml cytoplasm, see [111) were broken and extracts prepared, the assays were performed with -2.5 mg mycobacterial protein/M, equivalent to 1011 M. leprae/ml. Thus the bacterial cytoplasm, and any feedback inhibitors are diluted -100 fold. Another possibility could be that inhibitor-enzyme complexes were disrupted during the long (total 11 rain) ultrasonication period needed to break the bacteria.
Since the de novo biosynthesis of pyrimidines is completely inhibited in the intact M. leprae organisms isolated from the host tissue, it appears that M. leprae must use the scavenging pathways shown for pyrimidines [14] , taking advantage of the availability of pyrimidines in host cells. However, M. leprae has the capability of making its own pyrimidines at a considerable cost in energy and metabolic intermediates compared with scavenging them, when necessary. Whether the uracil base in M. leprae is derived from scavenged pyrimidines, or as the end product (as UMP) of de novo biosynthesis, all the pyrimidine bases--uracil, thymine and cytosine--can be synthesised from the uracil base [14] . Thus with its requirement for exogenous purines, but not pyrimidines, M. leprae is like most trypanosomes [15] and malarial parasites [16] . It is not as dependent on its host as Giardia larnblia [17] , Trichomonas vaginalis [18] or mycoplasmas [19] for instance, all of which require exogenous pyrimidines as well as purines. Therefore, it should be possible to culture M. leprae axenically in media free of pyrimidines, but including purines [5, 6] .
